[Dihydroergocristine in the treatment of Raynaud's disease].
D000293:Adolescent; D000328:Adult; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011928:Raynaud Disease / Q000188:drug therapy*
D004088:Dihydroergotoxine
La diidroergocristina nel trattamento della malattia di Raynaud.